Navigation Links
AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C
Date:12/10/2013

NORTH CHICAGO, Ill., Dec. 10, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) released phase III results for the investigational three direct-acting-antiviral (3D) regimen plus ribavirin in patients with chronic, genotype 1 (GT1) hepatitis C virus (HCV) infection. In the 394-patient SAPPHIRE-II study, 96 percent of patients who previously failed pegylated interferon and ribavirin treatment, including approximately 49 percent of who were prior null responders, achieved sustained virologic response at 12 weeks (SVR12) with the regimen. The majority of patients were GT1a, considered a difficult-to-treat subtype, and the SVR12 rates of GT1a and GT1b were 96 percent and 97 percent, respectively. Virologic relapse or breakthrough was noted in 2 percent of patients receiving the 3D regimen plus ribavirin. In addition, the discontinuation rate due to adverse events was 1 percent.

Globally, approximately 160 million people are chronically infected with hepatitis C[1]. AbbVie's multinational HCV program is the largest all-oral, interferon-free clinical program in GT1 patients being conducted to date[2]. GT1 (with subtypes 1a and 1b) is the most prevalent genotype worldwide, with a higher prevalence of 1a in the U.S. and 1b in Europe.

"SAPPHIRE-II demonstrates that treatment-experienced genotype 1 HCV patients achieved high rates of virologic response with AbbVie's interferon-free, all-oral 3D regimen plus ribavirin," said Scott Brun, M.D., vice president, pharmaceutical development, AbbVie. "Completion of the two placebo-controlled SAPPHIRE studies is an important step in AbbVie's HCV clinical development program.  We look forward to the results of studies looking at AbbVie's 3D regimen with and without ribavirin in different patients, as well as data from our dedicated stu
'/>"/>

SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. AbbVie Reports First-Quarter 2013 Financial Results
7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... CAMPBELL, Calif. , Nov. 28, 2014  (Booth ... announced the release of its newest product, DCMSYS Interface ... 30th through December 5th at McCormick Place, ... http://photos.prnewswire.com/prnh/20141126/161157 Designed for medical ... web-based third party application to upload any non-standard data ...
(Date:11/28/2014)... ATLANTA , Nov. 28, 2014 ... (Alimera), a pharmaceutical company that specializes in the ... has entered into a Securities Purchase Agreement with ... pursuant to which Alimera will issue shares of ... price of approximately $50.0 million upon the satisfaction ...
(Date:11/28/2014)... Chinese magnesium alloy maker DongGuan Eontec Co., ... alloy bone fixation screw has received Chinese regulatory inspection ... instrument and that the company acknowledges receipt of the ... Science and Technology Daily journalists Wang Xiangming and ... founder, Professor Li Yangde , has been a ...
Breaking Medicine Technology:Dicom Systems Announces WebBridge Interface at RSNA 2014 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4
... 2011 As part of its continuing efforts to ... of prescription medications, the National Association of Boards of ... InterConnect. NABP will now focus on working with participating ... vendors to finalize the software interface, so that PMP ...
... 6, 2011 Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, said ... conferences. On Thursday, June 9, the company ... Healthcare Conference. Gary F. Burbach, president and chief executive ...
Cached Medicine Technology:NABP PMP InterConnect Development Complete; PMPs Continue to Sign on to Participate in National System for Tracking Drug Abuse and Diversion 2Thoratec Announces Presentations at Upcoming Investor Conferences 2
(Date:11/28/2014)... 28, 2014 Dr. Diane Walder, one ... announced the addition of Dr. Bridgit Nolan to her ... practice after having completed her dermatology residency at the ... Walder invited Dr. Nolan to join her ... and cosmetic dermatology. Not only does Dr. Nolan strive ...
(Date:11/28/2014)... November 28, 2014 Novatus, a ... its Release v5.1 which provides customers with greater ... options. , “As we continue to evolve ... provide more functionality and improved performance in response ... CEO for Novatus. “With the enhancements that we ...
(Date:11/28/2014)... 28, 2014 On Monday, November 24, ... will present Feeding America Eastern Wisconsin with a check ... to donate a portion of proceeds to Feeding America ... “7 Days, 7 Ways to Save” with Turbana bananas ... were two for $4 and Turbana bananas were 29 ...
(Date:11/28/2014)... November 28, 2014 Mirena lawsuits ... forward in New Jersey’s Bergen County Superior Court, ... litigation established there is quickly approaching 1,300, Bernstein ... November 18th shows 1,293 lawsuits now pending in ... that allege complications resulting from spontaneous migration of ...
(Date:11/28/2014)... 28, 2014 Dr. Andrew Campbell, one ... announced the expansion of Quintessa Aesthetic Center into a ... located at W307 N1497 Golf Road in Suite 200 ... Dr. Campbell, the new Delafield location will offer a ... patients, including: Botox, filler injectables , micro laser ...
Breaking Medicine News(10 mins):Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2
... study suggests , , MONDAY, April 21 (HealthDay News) -- ... heart disease than women appear during the adolescent years, according ... teens. , "This is not what we would have predicted," ... at the University of Minnesota Children,s Hospital, and lead author ...
... BIRMINGHAM, Ala., April 21 Surgical Care Affiliates,("SCA") ... named president and,chief executive officer effective May 1, ... Snow, is resigning his position effective,April 30, 2008, ... on the company,s,board of directors., Mr. Hayek ...
... Up Bill Which Includes Grants to,Train Realtime Captioners ... Hearing Loss, VIENNA, Va., April 21 ... Reps. Judy Biggert,R-Ill.-13, and Danny K. Davis, D-Ill.-07, ... Lifelong Learning and Competitiveness, to,lend their support in ...
... wellness programs to reduce healthcare costs and ... improve ... United States earn approximately $48,000 annually(1), the amount,these families spend on ... salary. Aon Consulting,s 2008 Benefits and,Talent Survey revealed that the median ...
... Institute Science Journalism Award is Terry McDermott, a Los Angeles ... of research on memory, is titled Chasing Memory: One Mans ... a certificate of award and a cash prize of $5,000. ... an honorable mentionto Chip Rowe, senior editor at Playboy magazine, ...
... Funds in Ohio Sets Dangerous Precedent, WASHINGTON, ... Ohio,s tobacco settlement dollars for their originally intended,use, ... County Court of,Common Pleas for permission to intervene ... wisely dedicated by the State to,tobacco prevention and ...
Cached Medicine News:Health News:Heart Disease Risks Hit Boys in Teens 2Health News:SCA Names Andrew Hayek as New President and CEO 2Health News:NCRA Urges U.S. Reps. Danny Davis and Judy Biggert to Approve in Conference the Higher Education Reauthorization Bill Providing Closed Captioning for 30 Million Deaf and Hard-of-Hearing Americans 2Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 2Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 3Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 4Health News:Family Healthcare Contributions Edge Closer to Full Month's Salary, Says Aon Consulting 5Health News:Los Angeles Times writer wins Wistar Institute Science Journalism Award 2Health News:Los Angeles Times writer wins Wistar Institute Science Journalism Award 3Health News:Los Angeles Times writer wins Wistar Institute Science Journalism Award 4Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 2Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 3Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 4
... testing system from Del Mar Reynolds Medical. ... or bicycle ergometer, PC, Cart, isolation transformer ... the same CardioDirect patient interface module that ... ,The system is also available using the ...
... ExTOL systems feature your choice of ... electrocardiographs, an easy-to-operate monitor and the ... exercise stress testing systems also feature ... point, pre-programmed or custom protocols, and ...
The Urchin heart positioner provides excellent access to target coronaries while minimizing hemodynamic instability...
Part of the Octopus System which includes both the Starfish & Octopus3. The Starfish Heart Positioner simplifies cardiac positioning and minimizes the associated hemodynamic deterioration when compa...
Medicine Products: